-
When will the Guangzhou epidemic be brought under control
Time of Update: 2021-06-21
When will the Guangzhou epidemic be brought under control? ——Authoritative experts respond to the three key issues of the epidemic When will the Guangzhou epidemic be brought under
-
Policy·Resolve the introduction of human growth hormone into the inter-provincial collection of national medicines to open the "dual channel
Time of Update: 2021-06-12
With the continuous expansion of the scope of the centralized procurement of pharmaceuticals in my country and the continuous strengthening of policy, the impact on the medical and pharmaceutical industry is also deepening.
Previously, medical insurance negotiations had strict procedures for drugs to enter the hospital.
-
With a total value of US$189 million, Cinda Biologics has obtained the exclusive license of ROS1/NTRK inhibitor from Baoyuan Pharmaceutical in Greater China
Time of Update: 2021-06-11
According to the terms of the agreement, Cinda Bio will obtain the right to jointly develop and commercialize Ttaletrectinib in the Greater China Region with Baoyuan Pharmaceutical as an exclusive partner.
-
The new version of the medical insurance catalog is implemented today
Time of Update: 2021-03-23
On December 28, the results of the 2020 medical insurance negotiations were announced.
A total of 162 drugs were negotiated and 119 negotiations were successful.
-
Beijing: 40 key tasks to improve medical services
Time of Update: 2021-02-21
Level 3 hospitals to implement oral, obstetric prenatal check-up appointments, follow-up appointment rate of up to 90%.
Further improve emergency first aid services in medical institutions, pre-hospital emergency call satisfaction rate of more than 90%.
-
Five illegal drug advertisements, such as "Sanbao Capsules", were exposed
Time of Update: 2021-02-03
The products involved in these five serious illegal advertisements are: Yichun Jinbei Pharmaceutical Co., Ltd. produced the drug "Sanbao capsule (advertising name: Oriental Sanbao capsule)," Anshan Deshan Pharmaceutical Co., Ltd. produced the drug "Shulu tingling capsule (advertising name: this ancient live Shulu Ding pain capsule)," Harbin Jida Medical Device Factory produced medical equipment "prostate magnetic therapy bag ( advertising) The winning name: far-broadcast brand prostate magnetic treatment bag)", Wuhan Yiyuantang Biotech Co., Ltd.
-
BMJ: These drugs may not be helpful in treating persistent throat symptoms
Time of Update: 2021-01-30
the main outcome indicators of the trial, the study found that Lansolazole did not have a greater effect on patients with persistent throat symptoms than placebos.
-
Chinese officials have confirmed that the domestic new crown vaccine has been granted a patent
Time of Update: 2020-12-02
On February 15, 2020, the State Administration of Market Supervision, the State Drug Administration and the State Intellectual Property Office jointly issued Article 10 of Support for the Resumption of Work and Production, Article 3 of which stipulates that patent applications and trademark registrations involving the prevention and treatment of new crown pneumonia shall be examined and processed as a matter of priority upon request.
-
Introduction to the analysis method of raw materials for powder coatings (I
Time of Update: 2020-11-18
sample: the thermally conductive liquid is heated to 10 degrees C below the initial melting point and warms up at a rate of 1±0.1
principle is to heat samples in capillary tubes and observe changes in their phase change process or light transmission during phase change to determine the melting point.
-
Purchase of the first 90%, 231 hospitals commonly used drugs will carry out with volume procurement
Time of Update: 2020-10-24
On October 9th, Anhui Province's centralized pharmaceutical procurement platform issued a notice on soliciting and negotiating the price of clinically commonly used drugs in public medical institutions in Anhui Province in 2020 (hereinafter referred to as the "Draft for Comments"), which will negotiate the price of four types of drugs for clinically commonly used respiratory drugs, acid suppressants, liver and bile diseases, and medical imaging contrast agents.
-
How is Pfizer's high-selling of streaming products realized
Time of Update: 2020-10-15
We all know that Pfizer's Lipto and Live Hi is the original research drugs, after years of market cultivation, Lipto and Live Hi in the hospital and patient population reputation, recognition is very high, the author believes that this is precisely the key factor of Lipto and Live Joy sale.
-
In the first half of the year, imports of medical devices showed negative growth
Time of Update: 2020-10-11
In the recent medical high-value consumables belt procurement of the winning list, domestic equipment occupies the majority, many hospitals in the tender announcement explicitly do not accept tenders for imported products, or that non-specifically specified product categories do not accept imported products.
-
The Rockefeller Foundation and ACCESS Health publish authoritative reports, and Chinese experiences such as micro-medicine have been pushed globally
Time of Update: 2020-10-10
As one of the first enterprises to use digital technology to open up the "air battlefield" against the epidemic during the epidemic, micro-medicine was included as a representative case, the report details the micro-medical in all stages of anti-epidemic, different scenarios for the industry and the public professional information access, medical personnel coordination, online consultation, slow disease management, primary outbreak prevention and control and other medical health needs launched a variety of solutions.
-
From July 1st, a large number of drugs, medical insurance will no longer be reimbursed
Time of Update: 2020-07-24
Sorting / looking at 1, a large number of drugs, medical insurance is no longer reimbursed recently many medical insurance bureau intensive text, according to Thesaiblue incomplete statistics, Yunna
-
2020 ybzhan brand live public welfare activities, brand business hot registration
Time of Update: 2020-07-16
"Pharmaceutical Network Exhibition Report" In order to promote the high-end of the instrumentation brand, to help instrumentation enterprise brand development, July 13 - August 24, 2020, by the instr
